Trials / Completed
CompletedNCT02650063
A Pharmacokinetic Study of DE-117 Ophthalmic Solution in Healthy Adult Male Subjects - Phase I Study -
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Santen Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
The purposes of this study are to evaluate the safety and plasma pharmacokinetics of DE-117 ophthalmic solution (one drop once daily for 7 days) in healthy male adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DE-117 |
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2016-02-01
- Completion
- 2016-03-01
- First posted
- 2016-01-08
- Last updated
- 2016-06-29
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02650063. Inclusion in this directory is not an endorsement.